Navigation Links
Managed Health Care Associates, Inc. (MHA) Announces Expansion of Specialty Pharmaceutical Program
Date:2/14/2011

FLORHAM PARK, N.J., Feb. 14, 2011 /PRNewswire/ -- Managed Health Care Associates, Inc. (MHA),  a leading health care service company focused on alternate site health care providers, is pleased to announce  the expansion of its Specialty Pharmaceutical Program. This includes the addition of experienced specialty pharmaceutical professionals to the MHA Specialty program as well as new investments in improved data tools and services. The enhanced program is evidence of MHA's commitment to continuously develop and deliver solutions that enable MHA pharmacy members to participate in the growing specialty pharmacy market.

  • Lois Ann Murray has joined MHA as the Executive Director of Specialty Pharmaceutical Programs. Lois Ann has over 25 years of experience in the home infusion industry with the last seven years spent with a national specialty pharmacy provider where she served as Senior Vice President of Pharma Relations and Clinical Services. Her primary responsibilities at MHA include directly working with specialty pharmaceutical manufacturers and distributors as well as expanding MHA's Specialty Pharmacy Programs in developing fee for service contracts, adherence and persistency programs and access to limited distribution products.

  • Dr. Stacey Ness, Pharm.D has joined MHA as Associate Director of Specialty Pharmaceutical Programs.  Dr. Ness has an extensive specialty pharmaceutical background including her role as Clinical Services Director for one of the nation's leading specialty pharmacy providers.  Her most recent experience was as a Clinical Program Manager for one of the nation's largest payers. Dr. Ness also has expertise in clinical management, adherence and persistency programs, as well as cost optimization strategies of chronic diseases including oral oncology, multiple sclerosis, transplant, rheumatoid arthritis, hemophilia, psoriasis, hepatitis and HIV. Dr. Ness is active in the Consortium of Multiple Sclerosis Centers, Academy of Managed Care Pharmacy, National Home Infusion Association, Hematology and Oncology Pharmacy Association, and has served on the Minnesota Medicaid Drug Formulary Committee since 2008.

  • MHA has recently launched its expanded Specialty Pharmaceutical Provider Profile Tool. This expanded web based tool has been redesigned, based on feedback from specialty manufacturers and payers, to capture relevant data as it relates to individual pharmacies. This tool is an interactive database which categorizes each and every MHA Specialty Pharmacy Network member by area of expertise. This includes specific disease state expertise and patient support services in addition to overall clinical excellence.  

  • MHA's Pharmaceutical Data Services business unit (PDS) has expanded and is now actively working with specialty pharmaceutical manufacturers on multiple projects and contracts related to adherence and appropriate use of their specialty pharmaceutical products. PDS was initially developed as a data access and aggregation business designed to provide prescribing and treatment insights. This integrated process is now being utilized by more than six major specialty pharmaceutical manufacturers.

  • Michael J. Sicilian, MHA President commented, "The aforementioned investments MHA has made related to specialty focused tools and resources are in direct response to the feedback we are receiving from specialty pharmaceutical manufacturers and our respective pharmacy members. Specialty manufacturers are beginning to focus less on the class of trade and more on an individual pharmacy's expertise and ability to offer comprehensive specialty patient management programs.  It is also evident that these manufacturers are not looking at traditional GPO contracts that typically provide buy side discounts or rebates. They are focused on pharmacies that can deliver patient adherence, persistency, and clinical outcomes through dedicated clinical and patient focused programs."

    About MHAManaged Health Care Associates, Inc. (MHA) is a leading health care service company that offers a growing portfolio of services and solutions to support the diverse and complex needs of the alternate site health care provider. MHA provides expertise in Group Purchasing, Managed Care and Payer Contracting, Reimbursement Management, Specialty Pharmacy Solutions, Pharmaceutical Data Analytics, Clinical Pharmacy Software and Legislative Advocacy. Through the delivery of innovative and targeted health care services and solutions, MHA helps members increase operational efficiency, maximize business growth and provide optimum care for patients. For more information, visit www.mhainc.com. For More Information Contact:Angela ElsierDirector of MarketingManaged Health Care Associates, Inc.800-642-3020 X2870aelsier@mhainc.com
    '/>"/>

    SOURCE Managed Health Care Associates, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Prime Therapeutics President and CEO Eric Elliott Presents Keynote Address at 2011 PCMA Managed Markets Educational Forum
    2. Managed Health Care Associates, Inc. (MHA) Acquires Navigator, Inc.
    3. Guardian 24/7 Offers Remote High-Touch Health Care via Glowpoint Video Managed Services
    4. Creating a Platform for Managed Care Pull-Through Success in 2011
    5. Express Scripts Unveils New Opportunities to Drive Down Healthcare Costs; Presents Five Studies at Academy of Managed Care Pharmacy Conference
    6. Due to Rising Costs of Asthma and Chronic Obstructive Pulmonary Disease Drugs, Managed Care Organization Pharmacy Directors Will be Forced to Tighten Their Formularies
    7. Allied Telesis, Hosted PACS Solutions Join Forces to Deliver Managed Cloud-Based Picture Archiving and Communications Systems (PACS) Services
    8. Managed Care Pull-Through Initiatives Suffer from Poor Measurement of ROI
    9. Using the Market Research Function to Create Success in the Critical Managed Markets Sector
    10. Effective Market Research Critical to Success in Managed Markets
    11. New Research from Best Practices, LLC can Improve Formulary Access and Product Placement for Biopharma Companies: Managed Markets Market Research
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/19/2017)... , April 19, 2017 Cardiology devices segment is ... period The Cardiology Devices segment is likely to ... 15 Mn in 2018 over 2017. By the end of ... valuation close to US$ 700 Mn, expanding at a CAGR ... dominated the Asia Pacific reprocessed medical ...
    (Date:4/19/2017)... , April 19, 2017  Vanderbilt University Medical ... patients in Nashville , Tennesse have ... Esophageal Sphincter Stimulation for GERD (LESS GERD) trial. The ... provide long-term reflux control by restoring normal function to ... 65 million people in the United States ...
    (Date:4/19/2017)... HANOVER, N.J. , April 19, 2017 /PRNewswire/ ... conducted by the National Heart, Lung, and Blood ... (NIH) demonstrating that 58% of patients with treatment-naïve ... six months when treated with eltrombopag at the ... 1 . The study evaluated three sequential treatment ...
    Breaking Medicine Technology:
    (Date:4/25/2017)... Vegas, NV (PRWEB) , ... April 25, 2017 ... ... can now choose a modern procedure that achieves results in a fraction of ... in Las Vegas, NV, with Significance Dental Specialists, now offers this revolutionary ...
    (Date:4/25/2017)... GA (PRWEB) , ... April 25, 2017 , ... ... their neck and back pain with a reputable physician in their area, announces the ... CRM protects patient information for patients who are looking for reputable physicians to help ...
    (Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, a ... its patient care management module. Using this new feature, sleep physicians can now ... initiated on continuous positive airway pressure (CPAP), oral, or other forms of sleep ...
    (Date:4/25/2017)... ... ... Vetoquinol USA® , a world-class developer of veterinarian-approved ... EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin UCII ... The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and joints. ...
    (Date:4/24/2017)... ... April 24, 2017 , ... LG ... Your Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national ... which pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use kit ...
    Breaking Medicine News(10 mins):